These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4860366)

  • 1. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool.
    Danowski TS
    Metabolism; 1967 Sep; 16(9):865-9. PubMed ID: 4860366
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool. Concluding remarks.
    Danowski TS
    Ann N Y Acad Sci; 1968 Mar; 148(3):958-62. PubMed ID: 5241487
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
    Abramson E; Arky RA
    Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenformin therapy of chemical diabetes.
    Danowski TS; Sunder JH; Stephan T; Nolan S; Ohlsen PM; Ahmad U; Vidalon C; Wingert JP
    J Clin Pharmacol; 1974; 14(11-12):638-50. PubMed ID: 4140199
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenformin effect on body weight, lipids, and glucose regulation.
    Alterman SL; Lopez-Gomez AA
    Ann N Y Acad Sci; 1968 Mar; 148(3):884-91. PubMed ID: 4872312
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of hypoglycemic agents on blood lipids and body weight in ketoacidosis-resistant diabetics.
    Gershberg H; Javier Z; Hulse M; Hecht A
    Ann N Y Acad Sci; 1968 Mar; 148(3):914-24. PubMed ID: 4968572
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenformin effect on body weight, lipids and glucose regulation.
    Alterman SL
    Pol Arch Med Wewn; 1969; 42(3):291-7. PubMed ID: 5790046
    [No Abstract]   [Full Text] [Related]  

  • 8. Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin).
    Kissebah AH; Adams PW; Wynn V
    Diabetologia; 1974 Apr; 10(2):119-30. PubMed ID: 4844187
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of phenethylbiguanide on body weight and some serum lipid indices in obese subjects, obese diabetics and obese subjects with potential diabetes].
    Pompei A; Marcenaro A; Foppiani E; Jacopino GE
    Clin Ter; 1969 Dec; 51(6):541-60. PubMed ID: 5371379
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of the blood lipid pattern in diabetics under treatment with chlorpropamide and phenethyl-1-biguanide].
    Meduri D; Polito R
    Minerva Med; 1969 Jun; 60(49):2439-48. PubMed ID: 5802656
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of hypoglycemic therapy on blood lipids and body weight in diabetes mellitus.
    Mirsky S
    Ann N Y Acad Sci; 1968 Mar; 148(3):937-44. PubMed ID: 4872314
    [No Abstract]   [Full Text] [Related]  

  • 13. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
    Lang PD; Vollmar J; Klemens UH; von Löwis P; Gries FA; Koschinsky T; Huth K; Pilz E; Schlierf G; Kremer GJ; Lenhart P; Schwandt P; Hammerl H; Studlar M
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2280-6. PubMed ID: 4762828
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic abnormalities during combined sulphonylurea and phenformin therapy in maturity-onset diabetics.
    Nattrass M; Todd PG; Turnell D; Alberti KG
    Diabetologia; 1978 Jun; 14(6):389-95. PubMed ID: 669103
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic abnormalities in premature coronary disease: effects of therapy.
    Tzagournis M; Seidensticker JF; Hamwi GJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):945-57. PubMed ID: 4872315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin response to glucose in the presence of oral hypoglycemics.
    Arky RA; Abramson EA
    Ann N Y Acad Sci; 1968 Mar; 148(3):768-77. PubMed ID: 5241475
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of phenformin hydrochloride on serum cholesterol, triglycerides and body weight of nondiabetic hypercholesterolemic subjects.
    Burstein J; Jakobson T; Lindell KA; Nikiforow RE
    Ann Med Intern Fenn; 1968; 57(1):15-21. PubMed ID: 5726760
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenformin and lactic acidosis.
    Conlay LA; Loewenstein JE
    JAMA; 1976 Apr; 235(15):1575-8. PubMed ID: 946271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.